BioMaxima S.A. (FRA:944)

Market Cap	12.94M
Revenue (ttm)	13.85M
Net Income (ttm)	152.10K
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	85.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.440
Previous Close	2.350
Day's Range	2.440 - 2.490
52-Week Range	2.140 - 3.180
Beta	n/a
RSI	63.50
Earnings Date	Apr 29, 2026

About BioMaxima

BioMaxima S.A. manufactures and distributes microbiological media, reagents, and equipment for in vitro diagnostics in Poland. Its primary products include analyzers and diagnostic reagents for testing the biochemical parameters of blood and other body fluids; systems for the determination of drug resistance of microorganisms; quick diagnostic tests for detecting infectious diseases, cancer markers, heart attack markers, and addictive substances and readers; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and r...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1997
• Employees: 126
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 944

Financial Performance

In 2024, BioMaxima's revenue was 52.85 million, an increase of 12.96% compared to the previous year's 46.79 million. Earnings were 535,000, a decrease of -8.70%.

Financial numbers in PLN